DCE806201 Enrolling

Clinical Trial for Plaque Psoriasis (20 Weeks)

Treatment: Oral Age: 18-70 Years

Recruiting adults who are 18 to 70 years of age, inclusive with a clinical diagnosis of plaque psoriasis for 6 months or more, to participate in a clinical research trial.  Must have stable moderate to severe chronic plaque psoriasis (assessed at the Screening and Baseline visits).  Other eligibility criteria apply.

Participants will receive investigational oral treatment (active study drug) or placebo, in tablet form.  Study treatment and study-related assessments will be provided at no cost.  Reimbursement for study-related expenses may be provided.

Study participation will last about 20 weeks and involve about 8 visits to the study centre.

Participating Locations

United States

The following information is from

Last Update Posted: May 02, 2023


Dice Therapeutics

Study Description

  • Condition or Disease:

    Plaque Psoriasis

  • Ages Eligible for Study:

    18 to 70

Terms and Conditions –
Purpose of Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed to provide patients, family members, and members of the public current information about clinical research studies.

Participating Experts

Dr. Lawrence C. C. Cheung


Dr. Brandon Kirsch


You May Also Be Interested In

Similar Trials

No Similar Trials Found

Learn More About


Learn More
2022 all rights reserved probity medical research inc
find a trial
filter trials
Skip to content